As of July 2026 CRISPR Therapeutics has a market cap of โน555.82 Billion. This makes CRISPR Therapeutics the world's 2903th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jul 7th, 2026 the market cap of CRISPR Therapeutics was reported to be: